Related Experiment Video

Updated: Jun 21, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

Fungal infections in the ICU

Marya D Zilberberg1, Andrew F Shorr

  • 1Department of Health Policy and Management, School of Public Health and Health Sciences, University of Massachusetts, Amherst, MA 01003, USA. marya@evimedgroup.org

Infectious Disease Clinics of North America
|August 12, 2009
PubMed

Insights

Invasive fungal infections from Aspergillus and Candida pose significant risks, especially in immunocompromised patients. New diagnostics and treatments are emerging, requiring clinicians to stay updated on managing these severe diseases.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Aspergillus and Candida species are common causes of severe, life-threatening fungal infections.
  • Invasive fungal diseases (IFDs) significantly impact immunocompromised and critically ill patients, with mortality rates often exceeding 30%.
  • Current diagnostic methods for IFDs present challenges, necessitating the development of novel approaches.

Purpose of the Study:

  • To review the current landscape of Aspergillus and Candida infections in high-risk patient populations.
  • To highlight advancements in diagnostic modalities for invasive fungal diseases.
  • To discuss evolving therapeutic strategies for managing these infections.

Main Methods:

  • Literature review of recent studies on Aspergillus and Candida infections.
  • Analysis of diagnostic challenges and emerging technologies.
  • Synthesis of current and novel treatment options for IFDs.

Main Results:

  • Despite challenges, newer diagnostic tools are under investigation to improve early detection of IFDs.
  • The therapeutic landscape is evolving, with new antifungal agents becoming available.
  • Physicians require updated knowledge to effectively manage these complex infections.

Conclusions:

  • Managing invasive fungal infections caused by Aspergillus and Candida requires continuous learning due to rapid advancements.
  • Early and accurate diagnosis, coupled with appropriate antifungal therapy, is crucial for improving patient outcomes.
  • Staying abreast of the evolving literature is imperative for pulmonologists, intensivists, and other clinicians caring for at-risk patients.

More Related Videos

A Catheter-Related Candida albicans Infection Model in Mouse03:24

A Catheter-Related Candida albicans Infection Model in Mouse

Published on: March 22, 2024

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...